• Publications
  • Influence
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
PURPOSE To evaluate the efficacy and tolerance of irinotecan (CPT-11) in combination with oxaliplatin (L-OHP) plus fluorouracil (5-FU)/leucovorin (LV) (de Gramont regimen) as first-line treatment ofExpand
  • 119
  • 5
Sustained improvement of vascular endothelial function during anti‐TNFα treatment in rheumatoid arthritis patients
Objectives: Vascular endothelial function and common carotid artery intima–medial thickness (CCA‐IMT) are well‐established surrogate markers for early atherosclerotic disease, which accounts forExpand
  • 84
  • 4
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
BACKGROUND Cetuximab is an IgG1 monoclonal antibody targeting the epidermal growth factor receptor and is able to reverse the resistance to irinotecan in patients with metastatic colorectal cancerExpand
  • 58
  • 2
Standards of Practice for Superficial Femoral and Popliteal Artery Angioplasty and Stenting
This is a Standards of Practice document endorsed by CIRSE. The authors performed a literature review and provide recommendations and quality improvement guidelines based on the most recent andExpand
  • 53
  • 2
  • PDF
Nitinol Stents for Palliative Treatment of Malignant Obstructive Jaundice: Should We Stent the Sphincter of Oddi in Every Case?
AbstractPurpose: To evaluate the necessity of metallic stenting of the sphincter of Oddi in malignant obstructive jaundice when the tumor is more than 2 cm from the papilla of Vater. Methods:Expand
  • 30
  • 1
Sedations and analgesia in patients undergoing percutaneous transhepatic biliary drainage.
AIM To present our experience using intravenous sedoanalgesia for percutaneous biliary drainage. MATERIALS AND METHODS This study comprised 100 patients, all of whom were continuously monitoredExpand
  • 13
  • 1
PROPHYLAXIS WITH UROKINASE IN PEDIATRIC ONCOLOGY PATIENTS WITH CENTRAL VENOUS CATHETERS
This study evaluated the effects of urokinase in the prevention of central venous catheter (CVC)-related complications in children with malignancy. Fifteen patients with 16 CVCs (study group A)Expand
  • 45
Treatment of unresectable malignant abdominal, pelvic and thoracic tumors using abdominal pelvic and thoracic stop-flow chemotherapy.
BACKGROUND Stop-flow perfusion (SFP) has been recently used to enhance the effects of chemotherapy in patients with locally advanced tumors. PATIENTS AND METHODS Over a 2-year period we performedExpand
  • 8
Computed tomography 21 days after chemotherapy, three‐dimensional estimates of metastatic volume and the need for surgery in patients with germ cell cancer
Objective To assess whether the response visible on computed tomography (CT) 21 days after the first course of chemotherapy in patients with nonseminomatous germ cell tumour predicts the need forExpand
  • 5
Value of volume measurements in evaluating abdominal aortic aneurysms growth rate and need for surgical treatment.
PURPOSE To examine whether indices other than the traditionally used abdominal aortic aneurysm (AAA) maximum diameter, such as AAA volume, intraluminal thrombus (ILT) thickness and ILT volume, may beExpand
  • 17
  • PDF